The Panoptes system uses decoy cyclic nucleotides to defend against phage
- PMID: 41034579
- PMCID: PMC12657218
- DOI: 10.1038/s41586-025-09557-z
The Panoptes system uses decoy cyclic nucleotides to defend against phage
Abstract
Bacteria combat phage infection using antiphage systems and many systems generate nucleotide-derived second messengers upon infection that activate effector proteins to mediate immunity1. Phages respond with counter-defences that deplete these second messengers, leading to an escalating arms race with the host. Here we outline an antiphage system we call Panoptes that indirectly detects phage infection when phage proteins antagonize the nucleotide-derived second-messenger pool. Panoptes is a two-gene operon, optSE, wherein OptS is predicted to synthesize a nucleotide-derived second messenger and OptE is predicted to bind that signal and drive effector-mediated defence. Crystal structures show that OptS is a minimal CRISPR polymerase (mCpol) domain, a version of the polymerase domain found in type III CRISPR systems (Cas10). OptS orthologues from two distinct Panoptes systems generated cyclic dinucleotide products, including 2',3'-cyclic diadenosine monophosphate (2',3'-c-di-AMP), which we showed were able to bind the soluble domain of the OptE transmembrane effector. Panoptes potently restricted phage replication, but phages that had loss-of-function mutations in anti-cyclic oligonucleotide-based antiphage signalling system (CBASS) protein 2 (Acb2) escaped defence. These findings were unexpected because Acb2 is a nucleotide 'sponge' that antagonizes second-messenger signalling. Our data support the idea that cyclic nucleotide sequestration by Acb2 releases OptE toxicity, thereby initiating inner membrane disruption, leading to phage defence. These data demonstrate a sophisticated immune strategy that bacteria use to guard their second-messenger pool and turn immune evasion against the virus.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The University of Colorado Boulder and the University of California, Irvine, have patents pending for Panoptes and related technologies on which A.E.S., A.T.W. and B.R.M. are listed as inventors (provisional patent 63/772,257 filed 14 March 2025). The other authors declare no competing interests.
Figures
References
-
- Bernheim, A. & Sorek, R. The pan-immune system of bacteria: antiviral defence as a community resource. Nat. Rev. Microbiol.18, 113–119 (2020). - PubMed
-
- Georjon, H. & Bernheim, A. The highly diverse antiphage defence systems of bacteria. Nat. Rev. Microbiol.21, 686–700 (2023). - PubMed
-
- Millman, A. et al. An expanded arsenal of immune systems that protect bacteria from phages. Cell Host Microbe10.1016/j.chom.2022.09.017 (2022).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
